English

Eligibility Type 2 Diabetes NCT00508599

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetic for at least 6 months.
Description

Non-Insulin-Dependent Diabetes Mellitus disease length

Data type

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
healthy volunteers.
Description

Healthy Volunteers

Data type

boolean

Alias
UMLS CUI [1]
C1708335
type 2 diabetic subjects will have some nominal ability to secrete endogenous insulin as demonstrated by a post-stimulation c-peptide concentration of at least 6 ng/ml.
Description

Diabetes Mellitus, Non-Insulin-Dependent | insulin secretion | C-peptide measurement

Data type

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C1256369
UMLS CUI [3]
C0202100
all subjects will be mentally fit to give informed consent.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
hemoglobin a1c value below 11% (normal range = 4.4-5.8%) prior to study enrollment.
Description

Glucohemoglobin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0202054
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
hemoglobin a1c values > 11%
Description

Glycosylated haemoglobin increased

Data type

boolean

Alias
UMLS CUI [1]
C0019018
severe cardiovascular, hepatic, or renal disease
Description

Cardiovascular Disease Severe | Liver disease Severe | Kidney Disease Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0023895
UMLS CUI [2,2]
C0205082
UMLS CUI [3,1]
C0022658
UMLS CUI [3,2]
C0205082
past current history of drug or alcohol abuse
Description

Substance Use Disorders

Data type

boolean

Alias
UMLS CUI [1]
C0038586
diabetic gastroparesis
Description

Gastroparesis due to diabetes mellitus

Data type

boolean

Alias
UMLS CUI [1]
C0267176
uncontrolled hypertension ( > 140-90 mmhg)
Description

Uncontrolled hypertension

Data type

boolean

Alias
UMLS CUI [1]
C1868885
marked hyperlipidemia (serum ldl > 158mg/dl, or serum tg >691 mg/dl)
Description

Hyperlipidemia Marked | serum LDL | Serum thyroglobulin level

Data type

boolean

Alias
UMLS CUI [1,1]
C0020473
UMLS CUI [1,2]
C1706089
UMLS CUI [2]
C0036816
UMLS CUI [3]
C1271701
medications that interfere with glucose homeostasis
Description

Pharmaceutical Preparations Interfere with Glucose homeostasis

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C1326961
coumadin or other anticoagulation medications
Description

Coumadin | Anticoagulants

Data type

boolean

Alias
UMLS CUI [1]
C0699129
UMLS CUI [2]
C0003280
history of thrombosis or thrombophlebitis
Description

Thrombosis | Thrombophlebitis

Data type

boolean

Alias
UMLS CUI [1]
C0040053
UMLS CUI [2]
C0040046
current malignancy
Description

Malignant Neoplasms

Data type

boolean

Alias
UMLS CUI [1]
C0006826
smoker
Description

Tobacco use

Data type

boolean

Alias
UMLS CUI [1]
C0543414
pregnancy
Description

Pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0032961
contact precautions
Description

Contact precautions

Data type

boolean

Alias
UMLS CUI [1]
C1443873
Back to the top of the page

Similar models

Eligibility Type 2 Diabetes NCT00508599

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus disease length
Item
type 2 diabetic for at least 6 months.
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Healthy Volunteers
Item
healthy volunteers.
boolean
C1708335 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | insulin secretion | C-peptide measurement
Item
type 2 diabetic subjects will have some nominal ability to secrete endogenous insulin as demonstrated by a post-stimulation c-peptide concentration of at least 6 ng/ml.
boolean
C0011860 (UMLS CUI [1])
C1256369 (UMLS CUI [2])
C0202100 (UMLS CUI [3])
Informed Consent
Item
all subjects will be mentally fit to give informed consent.
boolean
C0021430 (UMLS CUI [1])
Glucohemoglobin measurement
Item
hemoglobin a1c value below 11% (normal range = 4.4-5.8%) prior to study enrollment.
boolean
C0202054 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Glycosylated haemoglobin increased
Item
hemoglobin a1c values > 11%
boolean
C0019018 (UMLS CUI [1])
Cardiovascular Disease Severe | Liver disease Severe | Kidney Disease Severe
Item
severe cardiovascular, hepatic, or renal disease
boolean
C0007222 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0023895 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0022658 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
Substance Use Disorders
Item
past current history of drug or alcohol abuse
boolean
C0038586 (UMLS CUI [1])
Gastroparesis due to diabetes mellitus
Item
diabetic gastroparesis
boolean
C0267176 (UMLS CUI [1])
Uncontrolled hypertension
Item
uncontrolled hypertension ( > 140-90 mmhg)
boolean
C1868885 (UMLS CUI [1])
Hyperlipidemia Marked | serum LDL | Serum thyroglobulin level
Item
marked hyperlipidemia (serum ldl > 158mg/dl, or serum tg >691 mg/dl)
boolean
C0020473 (UMLS CUI [1,1])
C1706089 (UMLS CUI [1,2])
C0036816 (UMLS CUI [2])
C1271701 (UMLS CUI [3])
Pharmaceutical Preparations Interfere with Glucose homeostasis
Item
medications that interfere with glucose homeostasis
boolean
C0013227 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C1326961 (UMLS CUI [1,3])
Coumadin | Anticoagulants
Item
coumadin or other anticoagulation medications
boolean
C0699129 (UMLS CUI [1])
C0003280 (UMLS CUI [2])
Thrombosis | Thrombophlebitis
Item
history of thrombosis or thrombophlebitis
boolean
C0040053 (UMLS CUI [1])
C0040046 (UMLS CUI [2])
Malignant Neoplasms
Item
current malignancy
boolean
C0006826 (UMLS CUI [1])
Tobacco use
Item
smoker
boolean
C0543414 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Contact precautions
Item
contact precautions
boolean
C1443873 (UMLS CUI [1])
Back to the top of the page